Skip to main content
  • Book
  • © 1976

Penicillins and Cephalosporins

Part of the book series: Chemotherapy (CT, volume 5)

Buying options

eBook USD 99.00
Price excludes VAT (USA)
  • ISBN: 978-1-4684-3126-1
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book USD 129.00
Price excludes VAT (USA)

This is a preview of subscription content, access via your institution.

Table of contents (67 chapters)

  1. Front Matter

    Pages i-xiv
  2. Clinical Relevance of Ampicillin/Cloxacillin for IV Use

    • C. Regamey, L. Barrelet, F. A. Waldvogel
    Pages 7-12
  3. Experiences with Amoxicillin in Full-Term and Pre-Term Neonates

    • L. Weingärtner, U. Sitka, R. Patsch
    Pages 13-18
  4. Pharmacological and Clinical Studies with Talampicillin, an Ester of Ampicillin

    • P. J. Wilkinson, A. L. Thomas, D. S. Reeves, J. Symonds
    Pages 31-36
  5. Determination of Indanyl Carbenicillin in Urine with Blood

    • M. Pina de Carvalho, A. Matos Ferreira
    Pages 71-73
  6. Indanyl Carbenicillin and Urinary Infections

    • R. Pedrotti, V. Forte
    Pages 87-92
  7. Carindacillin in the Therapy of Urinary Tract Infections

    • T. Germinale, C. Giglio
    Pages 99-101
  8. Urinary Levels of Carindacillin in the Pediatric Age

    • A. Ferro, G. Ceccarelli, G. R. Burgio
    Pages 103-107
  9. Clinical Pharmacological Studies with Bacampicillin

    • L. Magni, B. Sjöberg, J. Sjövall, J. Wessman
    Pages 109-114

About this book

The International Society o~ Chemotherapy meets every two years to review progress in chemotherapy of infections and of malignant disease. Each meeting gets larger to encompass the extepsion of chemotherapy into new areas. In some instances, expansion has been rapid, for example in cephalosporins, pen­ icillins and combination chemotherapy of cancer - in others slow, as in the field of parasitology. New problems of resistance and untoward effects arise; reduction of host toxicity without loss of antitumour activity by new substances occupies wide attention. The improved results with cancer chemotherapy, es­ pecially in leukaemias, are leading to a greater prevalence of severe infection in patients so treated, pharmacokinetics of drugs in normal and diseased subjects is receiving increasing attention along with related problems of bioavailability and interactions between drugs. Meanwhile the attack on some of the major bacterial infections, such as gonorrhoea and tubercu­ losis, which were among the first infections to feel the impact of chemotherapy, still continue to be major world problems and are now under attack with new agents and new methods. From this wide field and the 1,000 papers read at the Congress we have produced Proceedings which reflect the variety and vigour of research in this important field of medicine. It was not possible to include all of the papers presented at the Congress but we have attempted to include most aspects of cur­ rent progress in chemotherapy.

Keywords

  • cancer
  • chemotherapy
  • kinetics
  • pharmacokinetics
  • research
  • resistance
  • toxicity

Editors and Affiliations

  • The London Hospital Medical College, London, UK

    J. D. Williams

  • East Birmingham Hospital, Birmingham, UK

    A. M. Geddes

Bibliographic Information

Buying options

eBook USD 99.00
Price excludes VAT (USA)
  • ISBN: 978-1-4684-3126-1
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book USD 129.00
Price excludes VAT (USA)